PMID- 33478286 OWN - NLM STAT- MEDLINE DCOM- 20211217 LR - 20211217 IS - 1532-432X (Electronic) IS - 0363-0269 (Linking) VI - 45 IP - 1 DP - 2021 Jan TI - Comparison of Hematopoietic Stem Cell Transplantation Results in Patients with beta-Thalassemia Major from Three Different Graft Types. PG - 25-29 LID - 10.1080/03630269.2021.1872611 [doi] AB - Allogeneic hematopoietic stem cell transplantation (HSCT) is the curative therapy for beta-thalassemias that induces severe life-threatening complications. The human leukocyte antigen (HLA) registries and umbilical cord blood banks have carried out diligent searches to find matched unrelated donors (MUDs) for about 70.0% of patients from 2000 onwards. The chance of finding a non-sibling fully matched family donors is higher in some ethnic groups in which consanguineous marriages are common. We have studied and compared transplant complications and outcomes in different graft types (sibling, non-sibling family and unrelated). The non-sibling matched family donor (MFD) group consisted of four mothers, three fathers, five cousins, one paternal uncle and one paternal aunt. There was no significant difference in the mean transfused CD34+ cells, engraftment, median days of neutrophil and platelet recovery were achieved (p > 0.05). The distribution of postttransplant complication did not show any significant difference between groups (p > 0.05). In univariate analysis and multivarite analyses, age, gender, Pesaro risk group (I-II vs. III) and ABO incompatibilty demonstrated a significant difference in disease free survival (p < 0.05). Furthermore, in the second step of investigating overall survival (OS), age, gender and Pesaro risk group (I-II vs. III) showed a significant difference (p < 0.05). There was no significant difference in transplant-related mortality (TRM) between groups. Non-sibling related donor transplants are important for populations where consanguineous marriages are common. Transplant groups according to graft type had similar thalassemia-free survival (TFS) and OS when using a treosulfan-based regimen in our study. FAU - Aydogdu, Selime AU - Aydogdu S AUID- ORCID: 0000-0003-3380-3080 AD - Department of Pediatrics, Faculty of Medicine, Pediatric Bone Marrow Transplantation Unit, Bahcelievler Medical Park Hospital, Altinbas University, Istanbul, Turkey. FAU - Toret, Ersin AU - Toret E AUID- ORCID: 0000-0002-6379-8326 AD - Department of Pediatrics, Faculty of Medicine, Pediatric Bone Marrow Transplantation Unit, Bahcelievler Medical Park Hospital, Altinbas University, Istanbul, Turkey. FAU - Aksoy, Basak A AU - Aksoy BA AUID- ORCID: 0000-0001-8338-2101 AD - Department of Pediatrics, Faculty of Medicine, Pediatric Bone Marrow Transplantation Unit, Bahcelievler Medical Park Hospital, Altinbas University, Istanbul, Turkey. AD - Department of Pediatrics, Faculty of Medicine, Istinye University, Istanbul, Turkey. FAU - Aydin, Muhammed Fatih AU - Aydin MF AUID- ORCID: 0000-0001-6056-9360 AD - Department of Pediatrics, Faculty of Medicine, Pediatric Bone Marrow Transplantation Unit, Bahcelievler Medical Park Hospital, Altinbas University, Istanbul, Turkey. FAU - Cipe, Funda E AU - Cipe FE AUID- ORCID: 0000-0002-9718-7507 AD - Department of Pediatrics, Faculty of Medicine, Pediatric Bone Marrow Transplantation Unit, Bahcelievler Medical Park Hospital, Altinbas University, Istanbul, Turkey. FAU - Bozkurt, Ceyhun AU - Bozkurt C AUID- ORCID: 0000-0001-6771-9894 AD - Department of Pediatrics, Faculty of Medicine, Pediatric Bone Marrow Transplantation Unit, Bahcelievler Medical Park Hospital, Altinbas University, Istanbul, Turkey. AD - Department of Pediatrics, Faculty of Medicine, Istinye University, Istanbul, Turkey. FAU - Fisgin, Tunc AU - Fisgin T AUID- ORCID: 0000-0003-4467-9935 AD - Department of Pediatrics, Faculty of Medicine, Pediatric Bone Marrow Transplantation Unit, Bahcelievler Medical Park Hospital, Altinbas University, Istanbul, Turkey. LA - eng PT - Journal Article DEP - 20210121 PL - England TA - Hemoglobin JT - Hemoglobin JID - 7705865 SB - IM MH - Family MH - Fetal Blood MH - *Graft vs Host Disease MH - *Hematopoietic Stem Cell Transplantation MH - Humans MH - *beta-Thalassemia/therapy OTO - NOTNLM OT - Hematopoietic stem cell transplantation (HSCT) OT - non-sibling family donor OT - pediatrics OT - thalassemia OT - treosulfan EDAT- 2021/01/23 06:00 MHDA- 2021/12/18 06:00 CRDT- 2021/01/22 05:43 PHST- 2021/01/23 06:00 [pubmed] PHST- 2021/12/18 06:00 [medline] PHST- 2021/01/22 05:43 [entrez] AID - 10.1080/03630269.2021.1872611 [doi] PST - ppublish SO - Hemoglobin. 2021 Jan;45(1):25-29. doi: 10.1080/03630269.2021.1872611. Epub 2021 Jan 21.